Home / Pharma Healthcare / Global Extracorporeal Liver Assist Device (ELAD) Sales Market Report 2016

Global Extracorporeal Liver Assist Device (ELAD) Sales Market Report 2016

  • Id : RNR-15791
  • Category : Pharma Healthcare
  • Publish Date : 6-Oct
  • Pages : 126
  • Format : PDF
License Type

Description
Notes:
Sales, means the sales volume of Extracorporeal Liver Assist Device (ELAD)
Revenue, means the sales value of Extracorporeal Liver Assist Device (ELAD)

This report studies sales (consumption) of Extracorporeal Liver Assist Device (ELAD) in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
    Xenios AG (Germany)
    Abbott Diabetes Care, Inc. (USA)
    Vital Therapies, Inc. (USA)
    Baxter International, Inc. (USA)
    Asahi Kasei Medical Co., Ltd. (Japan)
    Medtronic, Inc. (USA)
    HeartWare International, Inc. (USA)
    Fresenius Medical Care AG & Co. KGaA (Germany)
    Thoratec Corp. (USA)
    Toray Medical Co., Ltd. (Japan)
    Nikkiso Co., Ltd. (Japan)
    Nipro Corporation (Japan)
    SynCardia Systems, Inc. (USA)
    Terumo Heart, Inc. (USA)
Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Extracorporeal Liver Assist Device (ELAD) in these regions, from 2011 to 2021 (forecast), like
    USA
    China
    Europe
    Japan
    India
    Southeast Asia
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
    Type I
    Type II
    Type III
Split by applications, this report focuses on sales, market share and growth rate of Extracorporeal Liver Assist Device (ELAD) in each application, can be divided into
    Application 1
    Application 2
    Application 3